Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.
Inflamm Bowel Dis
; 28(2): 318-321, 2022 02 01.
Article
in English
| MEDLINE | ID: covidwho-1545944
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Mesalamine
/
Angiotensin-Converting Enzyme 2
/
Intestines
Type of study:
Prognostic study
Limits:
Animals
Language:
English
Journal:
Inflamm Bowel Dis
Journal subject:
Gastroenterology
Year:
2022
Document Type:
Article
Affiliation country:
Ibd
Similar
MEDLINE
...
LILACS
LIS